1265 Mrv0541 02231215222D 17 18 0 0 1 0 999 V2000 3.7462 -1.0025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1814 -2.4546 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.7966 -2.3683 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6499 0.3073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0789 2.7822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0789 0.3073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3643 1.5447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.6663 -1.7872 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.0789 -0.5177 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.4113 -1.0025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4913 -1.7872 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.9761 -2.4546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7932 0.7197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3643 0.7197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7932 1.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0789 1.9573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5077 1.9573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 0 0 0 0 1 11 1 0 0 0 0 8 2 1 6 0 0 0 3 12 1 0 0 0 0 4 14 2 0 0 0 0 5 16 2 0 0 0 0 9 6 1 1 0 0 0 6 13 1 0 0 0 0 6 14 1 0 0 0 0 7 14 1 0 0 0 0 7 16 1 0 0 0 0 8 10 1 0 0 0 0 8 11 1 0 0 0 0 9 10 1 0 0 0 0 11 12 1 1 0 0 0 13 15 2 0 0 0 0 15 16 1 0 0 0 0 15 17 1 0 0 0 0 M END > DB01265 > drugbank > CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(=O)NC1=O > InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1 > IQFYYKKMVGJFEH-CSMHCCOUSA-N > C10H14N2O5 > 242.2286 > 242.090271568 > 5 > 31 > -0.0010947214185747138 > 23.196685232007372 > 1 > 3 > 0 > 0 > 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione > -1.32 > -1.1190535893333329 > -0.56 > 0 > 0 > 2 > 0 > 13.907922676786031 > 9.960276156373078 > -2.9780835894464888 > 99.09999999999998 > 55.412000000000006 > 2 > 1 > 6.68e+01 g/l > tetrahydrofolic acid > 0 > DB01265 > approved; investigational > Telbivudine > 1-(2-deoxy-β-L-ribofuranosyl)-5-methyluracil; 2'-Deoxy-L-thymidine; Beta-l-thymidine; Epavudine; L-deoxythymidine; L-DT; L-thymidine; LDT; Telbivudin; Telbivudina; Telbivudine; β-L-2'-deoxythymidine > Sebivo; Tyzeka $$$$